Genetron Holdings Ltd - ADR - SIC # 8011 - OFFICES AND CLINICS OF DOCTORS OF MEDICINE

Ticker Exchange SIC # Website Latest Ticker
GTH Nasdaq 8011 https://www.genetronhealth.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Genetron Holdings Ltd - ADR

Genetron Health Regains Compliance With Nasdaq Minimum Bid Price Requirement - Jan 18th, 2023 12:00 pm
Genetron Health Announces Receipt of Notification from Nasdaq - Nov 7th, 2022 11:00 am
Genetron Health Reports Unaudited Second Quarter 2022 Financial Results - Oct 12th, 2022 10:00 am
Genetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee - Sep 2nd, 2022 11:00 am
Genetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company - Aug 22nd, 2022 10:00 am
Strong week for Genetron Holdings (NASDAQ:GTH) shareholders doesn't alleviate pain of one-year loss - Aug 19th, 2022 11:18 am
Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day - Jun 16th, 2022 1:44 pm
Genetron Health Receives CAP Accreditation for its Maryland Laboratory - Jun 15th, 2022 10:00 am
Genetron Health Reports Unaudited First Quarter 2022 Financial Results - Jun 2nd, 2022 11:20 am
Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - Jun 2nd, 2022 10:00 am
Genetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-Genes - Jun 1st, 2022 10:00 am
Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022 - May 23rd, 2022 8:05 pm
Do Institutions Own Genetron Holdings Limited (NASDAQ:GTH) Shares? - May 3rd, 2022 1:11 pm
Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD® - Apr 19th, 2022 10:00 am
Genetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022 - Apr 8th, 2022 10:00 am
Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™’s potential in MRD Assay Developments - Apr 7th, 2022 10:00 am
Edited Transcript of GTH.OQ earnings conference call or presentation 29-Mar-22 12:30pm GMT - Mar 29th, 2022 12:30 pm
Genetron Health Announces Unaudited Fourth Quarter and Full Year 2021 Financial Results - Mar 29th, 2022 11:26 am
Genetron Health to Participate in the Credit Suisse Asian Investment Conference - Mar 21st, 2022 12:00 pm
Genetron Health to Announce Fourth Quarter and Full Year 2021 Unaudited Financial Results and Host Investor Call on March 29, 2022 - Mar 9th, 2022 9:05 pm